Surgery Partners Q1 2026: Steady Growth & Strategic Moves

Surgery Partners Q1 2026 earnings show steady progress, with net revenue of $811 million, a 4.4% increase in same-facility revenue, and adjusted EBITDA of $102 million. The company is focusing on robotics, physician recruitment, and new ASCs, while maintaining solid cost controls. Theyre also optimizing a surgical hospital asset to reduce debt and improve cash flow. Full-year guidance remains firm, with revenue projected between $3.35 and $3.45 billion and EBITDA of at least $530 million. The second quarter is on track to meet annual revenue targets, with strong physician partnerships and improved execution. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/d096f64e31a2443d